Concepedia

High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme

María Apellániz-Ruiz, Lucía Inglada‐Pérez, M.E.G. Naranjo, Lara M. Munín Sánchez, Veronika Mančíková, María Currás-Freixes, Aguirre A. de Cubas, Iñaki Comino‐Méndez, Soumaya Triki, Ahmed Rebaï,

The Pharmacogenomics Journal · 2014 · 66 citations · 17 references

DOIFull text

Open access

Concepts

References

17

A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data

Matthew Stephens, Peter Donnelly · The American Journal of Human Genetics · 2003 · 3.5K citations · Full text

, , +13

Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

Santiago Rodrı́guez, Tom R. Gaunt, Ian N. M. Day · American Journal of Epidemiology · 2009 · 1.1K citations · Full text

, , +6

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Daqing Wang, Yingying Guo, Steven Wrighton et al. · The Pharmacogenomics Journal · 2010 · 507 citations · Full text

, , +14

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism

Antonius E. van Herwaarden, Els Wagenaar, Cornelia M.M. van der Kruijssen et al. · Journal of Clinical Investigation · 2007 · 234 citations · Full text

, , +17

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem

Kathrin Klein, Ulrich M. Zanger · Frontiers in Genetics · 2013 · 222 citations · Full text

, , +12